Sihuan Pharmaceutical Holdings Group Ltd. Stock Shanghai - Hong Kong Stock Connect
Equities
460
BMG8162K1137
Pharmaceuticals
Sales 2024 * | 2.73B 379M 2.96B 519M | Sales 2025 * | 3.19B 442M 3.45B 605M | Capitalization | 5.25B 727M 5.68B 995M |
---|---|---|---|---|---|
Net income 2024 * | 107M 14.84M 116M 20.3M | Net income 2025 * | 337M 46.74M 365M 63.95M | EV / Sales 2024 * | 1.92 x |
Net cash position 2024 * | - 0 0 0 | Net cash position 2025 * | - 0 0 0 | EV / Sales 2025 * | 1.65 x |
P/E ratio 2024 * |
56.5
x | P/E ratio 2025 * |
14.1
x | Employees | - |
Yield 2024 * |
8.85% | Yield 2025 * |
8.85% | Free-Float | 44.97% |
Managers | Title | Age | Since |
---|---|---|---|
Wei Cheng Guo
FOU | Founder | 60 | 00-12-31 |
Gui Li Miao
DFI | Director of Finance/CFO | 50 | - |
Zhong Xin Jia
COO | Chief Operating Officer | 65 | 06-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Feng Sheng Che
FOU | Founder | 63 | 00-12-31 |
Wei Cheng Guo
FOU | Founder | 60 | 00-12-31 |
Jiong Long Zhang
CIO | Chief Investment Officer | 62 | 06-05-17 |
1st Jan change | Capi. | |
---|---|---|
+26.08% | 662B | |
+21.85% | 546B | |
-4.77% | 359B | |
+16.97% | 323B | |
+5.69% | 290B | |
+13.68% | 234B | |
+3.65% | 198B | |
-11.12% | 194B | |
+8.08% | 167B |